MedTrace Logo

HBOT for Patients With IC/FM (Interstitial Cystitis/Fibromyalgia)

NCT03693001 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2020-12-09

No results posted yet for this study

Summary

The investigators observed 12 fibromyalgia and interstitial cystitis patients undergoing hyperbaric oxygen oxygen treatment in a multiplace pressure chamber for 90 minutes, 40 treatment each, using an oro-nasal mask.

Conditions

  • Fibromyalgia
  • Interstitial Cystitis

Interventions

DEVICE

Intermittent Exposure to Oxygen via Oro-Nasal Mask

Patients were exposed to breathing 100% oxygen at 2 atmospheres absolute (ATA) in a multiplace pressure chamber for 90 minutes using an oro-nasal mask for 40 treatments over a 2 month period.

Sponsors & Collaborators

  • University of Padova

    collaborator OTHER

  • University of South Florida

    lead OTHER

Principal Investigators

  • Gerardo Bosco, MD · University of Padova

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-01
Primary Completion
2018-06-01
Completion
2018-06-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03693001 on ClinicalTrials.gov